TNF-α has been reported to increase CD44 expression on ovarian cancer cells upon the activation of the c-Jun NH2-terminal kinase [35] and, although not in the context of cancer, affects the glycosylation and sulfation of various glycoproteins [36]. This evidence concerns the gene CD44 and ovarian carcinoma.